The risks and trade-offs of duration compression in medical device projects are complex. Both crashing and fast tracking can offer time savings, but the potential impact on cost, quality, and compliance makes it something that must be handled carefully. Integrating more iterative or Agile-inspired approaches is one way to manage those risks without sacrificing time. While traditional Agile might not fully align with strict regulatory requirements, principles like early prototyping, continuous testing, and short development cycles can still be adapted to improve flexibility without compromising compliance. Breaking things down into smaller, testable components can sometimes allow for faster progress while still ensuring safety and accuracy. On whether to reduce scope or add resources under time pressure, adding resources tends to be the better long-term solution. Reducing scope might seem efficient at first, but it opens the door to missed functionality, potential rework, or even market failure if key features are cut. By investing more resources, the team can maintain quality and compliance while reducing the risk of issues that could arise later, problems that could be much more costly than any short-term profit loss.

It's never truly safe to use any method that causes an increase to risk or cost. After completing a risk analysis, duration compression should only be used if there's no safer option. In the case of an emergency authorization from the government during a disease outbreak results in the company short on time, and therefore needing to increase costs and/or manual workload, increasing many risks including contamination.

In this case, the benefits outweigh the risk because the public requires an immediate solution. Therefore, risk mitigation strategies should be considered to either reduce, transfer, or accept the risk of an activity. In cases when risk is increased for multiple projects at a time during an emergency outbreak, lag projects are useful in reducing the risk of a project without creating additional delay in the product project lifecycle.

The first step would definitely be to conduct a thorough risk analysis, considering things like the scope, resources, deadlines, and potential impacts on quality. Cost benefit analysis specifically can really help determine what may offer the best balance between saving time, reducing risk, and increasing costs. For medical device projects specifically, risk tolerance is often extremely low and strategies like crashing are almost never worth it because of the high risk they introduce. Quality, specifically safety for the patient, should never be compromised for time. Even if it means extending the timeline for a project, it is more important to maintain the quality of the project especially with extremely strict regulatory guidelines in place with the FDA and other regulatory boards around the world. This keeps the project going in general, as it avoids cutting corners and risking violating any regulatory guidelines or bringing harm to any patient or other company involved or affected by the project. 

In the case of a project manager‚ this would mean looking at the schedule first from the activities themselves and the nature of the critical path․ In fact‚ this process can be devoid of a decision on whether or not to fast track or crash․ The focus is on activities that actually drive the completion date․ Next‚ the manager must consider the interdependency of tasks․ If specific tasks require highly dependent outputs from previous tasks‚ implementing fast tracking can cause confusion or potential rework due to dependent tasks occurring simultaneously․ If these tasks are not too tightly bound‚ they may be capable of being done concurrently with little or no adverse effect․ It also matters how accurate the original time estimates are, because compressing a schedule that already has uncertainty can make things harder to control.

Crashing is typically the better option when tasks are well defined and adding resources can realistically shorten the duration. It gives more control, but it comes with higher costs. Fast tracking works better when tasks can be done in parallel, but it increases the chance of mistakes and coordination problems. In most cases, the decision comes down to balancing risk with cost and deciding which trade-off is more acceptable for the project.

In medical device projects, duration compression has to be handled carefully. It would not make sense to compress activities like testing, validation, or regulatory documentation since those are directly tied to safety and approval. However, earlier design work or internal development steps might be adjusted if the team can manage the added complexity. The goal is to avoid compressing any step that acts as a checkpoint for quality or compliance.

A useful way to think about it is like assembling a high-performance engine. Different parts can be built at the same time and more people can help speed up production, but the final assembly and tuning have to follow a strict order. If those last steps are rushed or done out of sequence, even a small mistake can cause the whole system to fail when it is put into use.

One question that could push this discussion further is how project teams can plan their schedules early on so that some tasks are already set up to run in parallel, instead of relying on compression later when time becomes limited.

From my perspective, the best way a project manager can make an informed decision between crashing and fast tracking is by carefully evaluating the trade-offs in terms of cost, risk, and impact on quality before making a move. I would look at which tasks are on the critical path, how sensitive they are to changes, and whether adding resources (crashing) would actually improve efficiency or just create more coordination issues. At the same time, I’d assess if any tasks can realistically overlap (fast tracking) without causing rework or safety concerns. Using data from past projects, risk assessments, and input from the team is key so the decision isn’t rushed or based on assumptions. When it comes to high-stakes medical device projects, I don’t think duration compression is ever completely “safe,” but I do think it can be used carefully in limited situations where it doesn’t compromise testing, validation, or regulatory requirements. For example, administrative or documentation tasks might be compressed, but anything involving patient safety, verification, or clinical performance should never be rushed. At the end of the day, protecting quality and safety has to come before meeting a deadline, even if that means accepting delays.

Initially, Project Managers should evaluate both the critical path and whether the time reductions in the overall project schedule will be impacted by the reductions before determining if they will crash or fast track an activity. In general, when crashing an activity you would be able to obtain additional resources for scheduling without greatly increasing the complexity of the project. In contrast, fast-tracking an activity is only used when there are some tasks that can overlap with little to no dependency/interaction. Project Managers should also evaluate costs and available resources, risk tolerance, risk opportunity, and likelihood of rework prior to choosing between methods. Furthermore, in most situations, a combination of both methods should be considered before relying solely on one method to complete the activity. Most importantly, the decision about crashing or fast-tracking activities should be data-driven based on risk assessments and cost-benefit analysis, which will allow Project Managers to choose the method that has the most significant overall negative impact while accomplishing their deadlines. 

I do not believe that any method of duration compression is inherently unsafe in a high-stakes medical device project, but it must be implemented carefully and judiciously; specifically, compression of critical path activities such as verification, validation, and regulatory compliance should never occur because they directly affect the safety of patients and the ability to obtain approval for products. Do you think there are specific phases in medical device development where duration compression is more acceptable, or should it be avoided altogether in highly regulated projects?

A way PMs can make an informed decision between utilizing crashing and fast-tracking is by questioning which decision is more reversible if something goes wrong. For example, since crashing means adding resources or supplemental support, then it can be scaled back later which may be less risky compared to fast-tracking activities that could lead to rework of downstream results. Therefore, the decision is not just about budgets versus a timely schedule, but it's also about a consolidation method that triggers consequences that are then easier to bounce back from. This can be most beneficial if assumptions are later considered false.

The decision should also depend on where the uncertainty originates in the project. If the uncertainty is a central resource one, then crashing may be most suitable. On the other hand, if the uncertainty is technical or design one then fast tracking could be risky, especially before knowledge becomes more refined and can lead to amplified failure. In medical device projects, the duration of compression is more secure only when its applied to low risk activities like the procurement of lead times, administrative approval or initial preparation work instead of compression activities related to design development, verification or customer safety. In that perspective, the question would be not whether duration compression is safe overall but whether teams are compressing the correct parts of the project while determining the parts where learning and precision can't be compromised. It can be a productive procedure to redefine preliminary deliverables so critical milestones can be achieved without compressing high-risk work.